Clinical Trial Update: Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating SPD489 in combination with an antidepressant for adults with major depressive disorder has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SPD489

Snippet

Sponsor: Shire | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-11-19